During the past decade, Liga Paranaense de Combate ao Cancer conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Liga Paranaense de Combate ao Cancer" are "Multiple Myeloma" (1 trials), "Prostatic Neoplasms" (1 trials), "Relapsed or Refractory Multiple Myeloma" (1 trials) and "Urothelial Carcinoma" (1 trials). Many other conditions were trialed in "Liga Paranaense de Combate ao Cancer" in a lesser frequency.

Most popular intervention types in "Liga Paranaense de Combate ao Cancer" are "Drug" (4 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Daratumumab" (2 trials), "Dexamethasone" (2 trials), "Pomalidomide" (2 trials), "Apalutamide" (1 trials) and "Bortezomib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Liga Paranaense de Combate ao Cancer" are 3 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Liga Paranaense de Combate ao Cancer". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Liga Paranaense de Combate ao Cancer, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Liga Paranaense de Combate ao Cancer, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".